In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 102
- City: SAN DIEGO
- Country: CALIFORNIA
- Ankara University Affiliated: Yes